Osteoporosis
Conference Coverage
Romosozumab may not increase cardiovascular risk after all
Could a cardioprotective effect of bisphosphonates in a pivotal clinical trial of romosozumab explain why the biologic was given a black-box...
From the Journals
Cumulative exposure to high-potency topical steroid doses drives osteoporosis fractures
"A 3% increase in the relative risk of osteoporosis and MOF was observed per doubling of the TCS dose."
From the Journals
Could an osteoporosis drug reduce need for hip revision surgery?
Denosumab, widely used to treat osteoporosis, may reduce the need for revision surgery due to aseptic loosening of the prosthesis in patients with...
From the Journals
Osteoporosis prevalence in PsA similar to general population
In this longitudinal cohort study, none of the factors associated with a higher likelihood of having a bone mineral density (BMD) test were...
Guidelines
EULAR recommendations define strategies to improve adherence in RMDs
A task force put together four overarching principles and nine points to consider to address adherence to both pharmacologic and nonpharmacologic...
From the Journals
Temper enthusiasm for long-term treatment with bisphosphonates?
A real-world study of nearly 30,000 women shows no benefit, in terms of hip fracture risk, between taking oral bisphosphonates for 10 years vs. 5...
From the Journals
Teenage bone density declines following sleeve gastrectomy
These patients may never reach peak bone mass.
From the Journals
Oral steroids plus PPIs increase osteoporotic fracture risk in RA patients
The risk of fracture in patients taking both drugs rose beyond what was seen in those taking either drug alone in this retrospective, population-...
From the Journals
To D or not to D? Vitamin D doesn’t reduce falls in older adults
A study of wide-ranging vitamin D dosing finds no reduction in risk of falls, while high doses may even increase risk. But editorialist says check...
From the Journals
Lung cancer CT scan is chance for ‘opportunistic’ osteoporosis check
"CT provides a more direct volumetric measure [than DXA] and is likely a more accurate method for BMD assessment," one expert says.
Conference Coverage
Osteoporosis drugs don’t worsen COVID-19 risk, may help
“What we observed is that there is no harm. Treatments should be continued.”